Equipping Medical Affairs for Hematology Launches

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Medical Affairs Product Launch in Hematology: Timelines, Resources, Success Factors, and Digital Influence”

STUDY OVERVIEW

In hematology, the success of a product launch hinges on the meticulous management of timelines, resource allocation, and digital integration. Medical Affairs teams play a pivotal role in aligning these elements to meet both scientific and market demands in this highly specialized therapeutic area.

Best Practices, LLC's benchmarking research delves into the critical components of successful hematology product launches, with a focus on timeline management, resource allocation, and the strategic use of digital tools. This study also explores key success factors and potential challenges, offering actionable strategies for optimizing launch outcomes in the hematology space.

KEY TOPICS

Hematology Launch Timelines, Preparedness Metrics, and Resourcing
Critical Success Factors and Major Pitfalls for Medical Affairs During Hematology Launches
Digital Influence on Hematology Launch Processes and Launch Tool Deployment

KEY METRICS

Hematology launch activities timeline for Medical Affairs
Medical Affairs launch staffing and budget per hematology product
Launch dashboard and performance tracking for hematology products
Medical Affairs’ pre and post launch budget allocation in hematology
Medical Affairs’ pre and post launch staffing allocation in hematology
Key success factors for Medical Affairs in hematology launches
Major challenges encountered by Medical Affairs during hematology launches
Post-pandemic digital technology utilization during hematology product launches
Digital launch tool deployment by Medical Affairs throughout the hematology launch process
Influence of digital activities and programs that Medical leads and supports in hematology
High-impact digital tools for Medical Affairs’ hematology launch activities

SAMPLE KEY FINDINGS

Launch Challenges: Poor cross-functional alignment and delayed involvement in launch activities are common pitfalls for Medical Affairs during hematology product launches.

METHODOLOGY

This benchmarking study engaged 17 Medical leaders from 14 leading life sciences organizations. The study insights are drawn primarily from Medical Directors and upper management executives, representing nearly 80% of the benchmark class.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Academic; Research; Biotech; Chemical; Consulting; Consumer Products; Health Care; Medical Device

Companies Profiled:
Apellis Pharmaceuticals; ASC Therapeutics; AstraZeneca; Duke University and Health System; Eurofarma; Genentech; Helsinn; Kyowa Kirin; MEDiSTRAVA; Novartis; Pixacore; Sandoz; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Medical Affairs Product Launch in Hematology: Timelines, Resources, Success Factors, and Digital Influence

ID: 5822

Features:

Pages/Slides: 34

Published: 2024

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6A094FE267F559C0300258B8D003C7874
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-product-launch-in-hematology-timelines-resources-success-factors-digital-influence?opendocument
18
19opendocument
203.238.82.77
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB